🚀 VC round data is live in beta, check it out!
Adheris Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Adheris Health and similar public comparables like IDEXX Laboratories, Roper Technologies, GE HealthCare, Veeva and more.
Adheris Health Overview
About Adheris Health
Adheris Health Ltd is an E-healthcare software development company that provides pharmacy-driven patient engagement solutions that include personalised patient experiences to help simplify the patient medication journey. The group is leveraging THRIV, a cloud-based, AI-enabled platform. Its solutions empower the pharmacy of the future through improved pharmacy workflow and patient engagement solutions.
Founded
2010
HQ
Employees
N/A
Website
N/A
Financials (LTM)
Market Cap
—
Adheris Health Financials
Adheris Health reported last 12-month revenue of $41M and negative EBITDA of ($7M).
In the same LTM period, Adheris Health generated ($7M) in EBITDA losses and had net loss of ($39M).
Revenue (LTM)
Adheris Health P&L
In the most recent fiscal year, Adheris Health reported revenue of — and net income of —.
Adheris Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $41M | XXX | — | XXX | XXX | XXX |
| EBITDA | ($7M) | XXX | — | XXX | XXX | XXX |
| EBITDA Margin | (17%) | XXX | — | XXX | XXX | XXX |
| Net Profit | ($39M) | XXX | — | XXX | XXX | XXX |
| Net Margin | (96%) | XXX | — | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Adheris Health Stock Performance
Adheris Health has current market cap of —.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| — | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAdheris Health Valuation Multiples
Adheris Health Financial Valuation Multiples
As of March 20, 2026, Adheris Health has market cap of —.
Equity research analysts estimate Adheris Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 |
|---|
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Adheris Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Adheris Health Margins & Growth Rates
Adheris Health's revenue in the last fiscal year grew by 0%.
Adheris Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | (17%) | XXX | — | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 0% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Adheris Health Public Comps
See public comps and valuation multiples for other Digital Therapeutics and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| IDEXX Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Roper Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| GE HealthCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Veeva | XXX | XXX | XXX | XXX | XXX | XXX |
| IQVIA | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Adheris Health M&A Activity
Adheris Health acquired XXX companies to date.
Last acquisition by Adheris Health was on XXXXXXXX, XXXXX. Adheris Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Adheris Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAdheris Health Investment Activity
Adheris Health invested in XXX companies to date.
Adheris Health made its latest investment on XXXXXXXX, XXXXX. Adheris Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Adheris Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Adheris Health
| When was Adheris Health founded? | Adheris Health was founded in 2010. |
| Where is Adheris Health headquartered? | Adheris Health is headquartered in Australia. |
| Is Adheris Health publicly listed? | Yes, Adheris Health is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Adheris Health? | Adheris Health trades under MDR ticker. |
| When did Adheris Health go public? | Adheris Health went public in 2011. |
| Who are competitors of Adheris Health? | Adheris Health main competitors are IDEXX Laboratories, Roper Technologies, GE HealthCare, Veeva. |
| What is the current revenue of Adheris Health? | Adheris Health's last 12 months revenue is $41M. |
| Is Adheris Health profitable? | No, Adheris Health is not profitable. |
| What is the current EBITDA of Adheris Health? | Adheris Health has negative EBITDA and is not profitable. |
| What is Adheris Health's EBITDA margin? | Adheris Health's last 12 months EBITDA margin is (17%). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.